keyword
MENU ▼
Read by QxMD icon Read
search

Lung cancer,meta-analysis

keyword
https://www.readbyqxmd.com/read/29455641/circadian-pathway-genetic-variation-and-cancer-risk-evidence-from-genome-wide-association-studies
#1
Simone Mocellin, Saveria Tropea, Clara Benna, Carlo Riccardo Rossi
BACKGROUND: Dysfunction of the circadian clock and single polymorphisms of some circadian genes have been linked to cancer susceptibility, although data are scarce and findings inconsistent. We aimed to investigate the association between circadian pathway genetic variation and risk of developing common cancers based on the findings of genome-wide association studies (GWASs). METHODS: Single nucleotide polymorphisms (SNPs) of 17 circadian genes reported by three GWAS meta-analyses dedicated to breast (Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE) Consortium; cases, n = 15,748; controls, n = 18,084), prostate (Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium; cases, n = 14,160; controls, n = 12,724) and lung carcinoma (Transdisciplinary Research In Cancer of the Lung (TRICL) Consortium; cases, n = 12,160; controls, n = 16,838) in patients of European ancestry were utilized to perform pathway analysis by means of the adaptive rank truncated product (ARTP) method...
February 19, 2018: BMC Medicine
https://www.readbyqxmd.com/read/29440919/efficacy-and-safety-of-cox-2-inhibitors-for-advanced-non-small-cell-lung-cancer-with-chemotherapy-a-meta-analysis
#2
Ping Dai, Jing Li, Xiao-Ping Ma, Jian Huang, Juan-Juan Meng, Ping Gong
Background: The study of cyclooxygenase-2 (COX-2) inhibitors is now mired in controversy. We performed a meta-analysis to assess the efficacy and safety profile of COX-2 inhibitors in patients with advanced non-small-cell lung cancer (NSCLC). Patients and methods: A literature search of PubMed, EMBASE, the Cochrane Central databases, and ClinicalTrials.gov, up until March 26, 2017, identified relevant randomized controlled trials. Data analysis was performed using Stata 12...
2018: OncoTargets and Therapy
https://www.readbyqxmd.com/read/29440914/associations-between-abcg2-gene-polymorphisms-and-gefitinib-toxicity-in-non-small-cell-lung-cancer-a-meta-analysis
#3
Lina Tang, Chunling Zhang, Hairong He, Zhenyu Pan, Di Fan, Yinli He, Haisheng You, Yuanjie Li
Background: Gefitinib is frequently used to treat patients with non-small cell lung cancer (NSCLC) and is excreted out from cells via the ATP-binding cassette transporter ABCG2. ABCG2 gene polymorphisms have been suggested to be associated with ABCG2 protein expression and function and may influence the risk of gefitinib toxicity in NSCLC patients. Previous studies on the associations between ABCG2 gene polymorphisms and the toxicity of gefitinib in NSCLC patients have produced conflicting results...
2018: OncoTargets and Therapy
https://www.readbyqxmd.com/read/29437041/preoperative-exercise-halves-the-postoperative-complication-rate-in-patients-with-lung-cancer-a-systematic-review-of-the-effect-of-exercise-on-complications-length-of-stay-and-quality-of-life-in-patients-with-cancer
#4
REVIEW
Daniel Steffens, Paula R Beckenkamp, Mark Hancock, Michael Solomon, Jane Young
OBJECTIVE: To investigate the effectiveness of preoperative exercises interventions in patients undergoing oncological surgery, on postoperative complications, length of hospital stay and quality of life. DESIGN: Intervention systematic review with meta-analysis. DATA SOURCES: MEDLINE, Embase and PEDro. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Trials investigating the effectiveness of preoperative exercise for any oncological patient undergoing surgery were included...
February 1, 2018: British Journal of Sports Medicine
https://www.readbyqxmd.com/read/29436188/peptide-nucleic-acid-clamping-and-direct-sequencing-in-the-detection-of-oncogenic-alterations-in-lung-cancer-systematic-review-and-meta-analysis
#5
Jae Uk Song, Jonghoo Lee
PURPOSE: Molecular testing in non-small cell lung cancer (NSCLC) aids in identifying oncogenic alterations. The aim of this study was to compare the rates of detection of oncogenic alterations and responsiveness to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) according to EGFR mutation status as determined by peptide nucleic acid (PNA) clamping or direct sequencing (DS). MATERIALS AND METHODS: We performed a systematic literature search using MEDLINE, EMBASE, and the Cochrane Central Register...
March 2018: Yonsei Medical Journal
https://www.readbyqxmd.com/read/29435629/long-term-survival-and-prognostic-factors-of-pulmonary-metastasectomy-in-liver-cancer-a-systematic-review-and-meta-analysis
#6
Chong Wang, Lei Yang, Zikun Liang, Yaodong Liu, Shuku Liu
BACKGROUND: Lung is the most common extrahepatic metastatic organ of liver cancer. Surgical resection is a common local treatment for pulmonary metastasis. But the long-term prognosis of pulmonary metastasectomy varies greatly due to the small sample size and different results of previous studies. Therefore, we conducted this meta-analysis to evaluate the combined 5-year overall survival (OS) rate and prognostic factors after pulmonary metastasectomy in liver cancer. METHODS: Key words such as liver cancer pulmonary metastasis and metastasectomy were retrieved firstly in PubMed, Cochrane Library, Embase and Chinese Wanfang databases...
February 12, 2018: World Journal of Surgery
https://www.readbyqxmd.com/read/29434863/identification-of-common-key-genes-in-breast-lung-and-prostate-cancer-and-exploration-of-their-heterogeneous-expression
#7
Richa K Makhijani, Shital A Raut, Hemant J Purohit
Cancer is one of the leading causes of mortality worldwide, and in particular, breast cancer in women, prostate cancer in men, and lung cancer in both women and men. The present study aimed to identify a common set of genes which may serve as indicators of important molecular and cellular processes in breast, prostate and lung cancer. Six microarray gene expression profile datasets [GSE45827, GSE48984, GSE19804, GSE10072, GSE55945 and GSE26910 (two datasets for each cancer)] and one RNA-Seq expression dataset (GSE62944 including all three cancer types), were downloaded from the Gene Expression Omnibus database...
February 2018: Oncology Letters
https://www.readbyqxmd.com/read/29433902/safety-and-efficacy-of-pd-1-pd-l1-inhibitors-in-treatment-naive-and-chemotherapy-refractory-patients-with-non-small-cell-lung-cancer-a-systematic-review-and-meta-analysis
#8
Monica Khunger, Prantesh Jain, Sagar Rakshit, Vinay Pasupuleti, Adrian V Hernandez, James Stevenson, Nathan A Pennell, Vamsidhar Velcheti
INTRODUCTION: Programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) inhibitors show significant clinical activity in non-small-cell lung carcinoma (NSCLC). However, there is a relative lack of data on comparative efficacy of these drugs in the first-line setting versus chemotherapy-treated patients. We compared the efficacy and toxicity of these drugs in these 2 distinct groups of patients. MATERIALS AND METHODS: Electronic databases (PubMed-Medline, EMBASE, Scopus) and major conference proceedings were systematically searched for all phase I to III clinical trials in NSCLC using PD-1/PD-L1 inhibitors...
January 10, 2018: Clinical Lung Cancer
https://www.readbyqxmd.com/read/29423118/the-efficacy-and-safety-of-anti-pd-1-pd-l1-antibody-therapy-versus-docetaxel-for-pretreated-advanced-nsclc-a-meta-analysis
#9
Guanghong Huang, Xin Sun, Dapeng Liu, Yunfeng Zhang, Boxiang Zhang, Guodong Xiao, Xiang Li, Xiao Gao, Chenhao Hu, Meng Wang, Hong Ren, Sida Qin
Antibodies against the immune checkpoint proteins PD-1 and PD-L1 are novel therapeutic drugs for the treatment of advanced non-small cell lung cancer (NSCLC). Many clinical trials involving these drugs achieved breakthroughs in patients previously treated for advanced NSCLC. However, the results of these clinical studies are not consistent. In this report, we performed a meta-analysis to assess the efficacy and safety of anti-PD-1/PD-L1 antibodies compared with docetaxel treatment for advanced NSCLC patients from 5 randomized clinical trials...
January 9, 2018: Oncotarget
https://www.readbyqxmd.com/read/29422423/use-of-artesunate-in-non-malarial-indications
#10
REVIEW
A Raffetin, F Bruneel, C Roussel, M Thellier, P Buffet, E Caumes, S Jauréguiberry
INTRODUCTION: Artesunate and other artemisinin derivatives are used in various infectious and non-infectious diseases. We aimed to analyze available data on artesunate and artemisinin derivatives activity in humans and their potential clinical benefits in non-malarial indications. MATERIAL AND METHODS: Literature review performed on PubMed and the Cochrane Library databases using the PRISMA method. We analyzed studies published in English from January 2008 to August 2017 using the same indicators of drug efficacy...
February 5, 2018: Médecine et Maladies Infectieuses
https://www.readbyqxmd.com/read/29421442/rage-may-act-as-a-tumour-suppressor-to-regulate-lung-cancer-development
#11
Shuangshuang Wu, Liping Mao, Yan Li, Yuan Yin, Weiwei Yuan, Yujia Chen, Wenlong Ren, Xiao Lu, Yue Li, Lei Chen, Bo Chen, Wei Xu, Tian Tian, Yihua Lu, Liying Jiang, Xun Zhuang, Minjie Chu, Jianqing Wu
Although the correlation of the RAGE rs2070600 polymorphism and cancer risk has been confirmed, detailed studies with functional and experimental evaluations are lacking. In this study, we first aimed to examine whether this polymorphism is associated with cancer risk based on the latest published data, and consistent with previous meta-analyses, a significant association between the rs2070600 polymorphism and cancer risk was observed (A versus G: OR = 1.25; 95% CI = 1.12-1.40). In additional stratified analyses based on cancer type, rs2070600 was significantly associated with an increased risk of lung cancer (A versus G: OR = 1...
February 5, 2018: Gene
https://www.readbyqxmd.com/read/29419756/dietary-cholesterol-intake-and-risk-of-lung-cancer-a-meta-analysis
#12
REVIEW
Xiaojing Lin, Lingli Liu, Youyun Fu, Jing Gao, Yunyun He, Yang Wu, Xuemei Lian
Multiple epidemiologic studies have evaluated the relationship between dietary cholesterol and lung cancer risk, but the association is controversial and inconclusive. A meta-analysis of case-control studies and cohort studies was conducted to evaluate the relationship between dietary cholesterol intake and lung cancer risk in this study. A relevant literature search up to October 2017 was performed in Web of Science, PubMed, China National Knowledge Infrastructure, Sinomed, and VIP Journal Integration Platform...
February 8, 2018: Nutrients
https://www.readbyqxmd.com/read/29416694/prognostic-and-clinicopathological-significance-of-microrna-494-overexpression-in-cancers-a-meta-analysis
#13
Zhenxian Xiang, Min Sun, Zewei Yuan, Chunxiao Zhang, Jun Jiang, Sihao Huang, Bin Xiong
MicroRNA-494 was revealed as an attractive prognostic biomarker in recent studies. Nevertheless, the prognostic value of microRNA-494 in cancers remains controversial. Current meta-analysis aims to elucidate the precise predictive value of microRNA-494 in various cancers. Eligible studies were identified through multiple search strategies, the hazard ratios (HRs) and their confidence interval (CI) for patient prognostic outcomes were extracted and estimated. The pooled results of fifteen studies indicated that elevated expression of microRNA-494 implies a good overall survival of cancer patients (HR = 0...
January 2, 2018: Oncotarget
https://www.readbyqxmd.com/read/29416351/the-prognostic-role-of-gas6-axl-axis-in-solid-malignancies-a-meta-analysis-and-literature-review
#14
Sheng Zhang, Xiang Shang Xu, Jie Xi Yang, Jian Hui Guo, Teng Fei Chao, YiXin Tong
Background: Axl is a receptor tyrosine kinase that is involved in many pathological conditions and carcinogenesis. Gas6 is the major ligand of Axl. Activation of Gas6/Axl pathway is essential for cancer development. However, its prognostic significance in solid tumors remains unclear. Therefore, we performed this meta-analysis to elucidate the prognostic impact of Axl. Methods: Published studies on Axl or Gas6 expression and overall survival (OS) and/or disease-free survival (DFS) were searched from databases...
2018: OncoTargets and Therapy
https://www.readbyqxmd.com/read/29409466/frequency-of-the-acquired-resistant-mutation-t790%C3%A2-m-in-non-small-cell-lung-cancer-patients-with-active-exon-19del-and-exon-21-l858r-a-systematic-review-and-meta-analysis
#15
Zan-Feng Wang, Sheng-Xiang Ren, Wei Li, Guang-Hui Gao
BACKGROUND: Although EGFR-TKI is the preferred treatment for NSCLC patients with sensitive mutations, subsequent drug resistance is almost inevitable. The specific mechanisms of EGFR-TKI drug resistance can be identified through repeat biopsy. METHODS: To better understand the clinical characteristics of TKI resistance in NSCLC patients, we retrospectively reviewed studies of acquired TKI drug resistance using repeat biopsy from the last decade. The relevant literature was retrieved from January 2005 to August 2015 in the databases Medline and Embase...
February 6, 2018: BMC Cancer
https://www.readbyqxmd.com/read/29409126/withdrawn-cranial-irradiation-for-preventing-brain-metastases-of-small-cell-lung-cancer-in-patients-in-complete-remission
#16
REVIEW
(no author information available yet)
BACKGROUND: Prophylactic cranial irradiation halves the rate of brain metastases in patients with small cell lung cancer. Individual randomized trials conducted on patients in complete remission were unable to clarify whether this treatment improves survival. OBJECTIVES: This study aims to test whether prophylactic cranial irradiation prolongs survival of patients with small cell lung cancer in complete remission. SEARCH METHODS: Published and unpublished trials were eligible...
February 6, 2018: Cochrane Database of Systematic Reviews
https://www.readbyqxmd.com/read/29398920/prognostic-role-of-hsf1-overexpression-in-solid-tumors-a-pooled-analysis-of-3-159-patients
#17
Tao Wan, Jing Shao, Bin Hu, Gang Liu, Peng Luo, Yanming Zhou
Background and objective: HSF1 is reported to be overexpressed in various solid tumors and play a pivotal role in cancer progression. A meta-analysis was conducted to assess the potential prognostic role of HSF1 in patients with solid tumors. Methods: An extensive electronic search of three databases was performed for relevant articles. The pooled hazard ratios (HRs) or odds ratios with their corresponding 95% CI were calculated with a random-effects model. Heterogeneity and publication bias analyses were also conducted...
2018: OncoTargets and Therapy
https://www.readbyqxmd.com/read/29394946/clinical-value-of-mir-198-5p-in-lung-squamous-cell-carcinoma-assessed-using-microarray-and-rt-qpcr
#18
Yue-Ya Liang, Jia-Cheng Huang, Rui-Xue Tang, Wen-Jie Chen, Peng Chen, Wei-Luan Cen, Ke Shi, Li Gao, Xiang Gao, An-Gui Liu, Xiao-Tong Peng, Gang Chen, Su-Ning Huang, Ye-Ying Fang, Yong-Yao Gu
BACKGROUND: To examine the clinical value of miR-198-5p in lung squamous cell carcinoma (LUSC). METHODS: Gene Expression Omnibus (GEO) microarray datasets were used to explore the miR-198-5p expression and its diagnostic value in LUSC. Real-time reverse transcription quantitative polymerase chain reaction was used to evaluate the expression of miR-198-5p in 23 formalin-fixed, paraffin-embedded (FFPE) LUSC tissues and corresponding non-cancerous tissues. The correlation between miR-198-5p expression and clinic pathological features was assessed...
February 2, 2018: World Journal of Surgical Oncology
https://www.readbyqxmd.com/read/29392400/extranodal-extension-of-nodal-metastases-is-a-poor-prognostic-moderator-in-non-small-cell-lung-cancer-a-meta-analysis
#19
Claudio Luchini, Nicola Veronese, Alessia Nottegar, Monica Cheng, Takuma Kaneko, Camilla Pilati, Fabrizio Tabbò, Brendon Stubbs, Antonio Pea, Fabio Bagante, Jacopo Demurtas, Matteo Fassan, Maurizio Infante, Liang Cheng, Aldo Scarpa
Extranodal extension (ENE) of nodal metastasis is defined as the extension of metastatic cells through the nodal capsule into the perinodal tissue. This morphological parameter, recently proposed as an important prognostic factor in different types of malignancy, has not been included in the TNM staging system for non-small cell lung cancer (NSCLC). In this systematic review with meta-analysis, we weighted the prognostic role of ENE in patients with lymph node-positive NSCLC. Two independent authors searched SCOPUS and PubMed through 28 February 2017...
February 1, 2018: Virchows Archiv: An International Journal of Pathology
https://www.readbyqxmd.com/read/29392334/effect-of-postsurgical-rehabilitation-programmes-in-patients-operated-for-lung-cancer-a-systematic-review-and-meta-analysis
#20
Maja S Sommer, Maja E B Staerkind, Jan Christensen, Jette Vibe-Petersen, Klaus R Larsen, Jesper Holst Pedersen, Henning Langberg
OBJECTIVE: To review the evidence concerning the effects of postoperative exercise interventions on exercise capacity and health-related quality of life following resection for non-small cell lung cancer, and to review whether different initiation times of exercise produce different effects on exercise capacity. DATA SOURCES: Comprehensive literature search of MEDLINE, Embase, CENTRAL, CINAHL and PEDro. STUDY SELECTION: Randomized controlled trials examining the effects of exercise interventions were eligible for inclusion...
January 25, 2018: Journal of Rehabilitation Medicine
keyword
keyword
15077
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"